Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 1.331.191.221.261.21

What is the latest Fixed Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Fixed Capital/Sales ratio of PIRAMAL PHARMA is 1.33 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20261.33
Mar20251.19
Mar20241.22
Mar20231.26
Mar20221.21

How is Fixed Capital/Sales of PIRAMAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2026 1.33
11.76
Mar2025 1.19
-2.46
Mar2024 1.22
-3.17
Mar2023 1.26
4.13
Mar2022 1.21 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Fixed Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,306.5 Cr 0.6% -2.4% -3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.6%

-2.4%

-3.7%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses